Curiox Biosystems reported preliminary Q3 2026 results (consolidated): Revenue of KRW 1.5 billion (+7.7% year over year), operating profit of -KRW 4 billion (-47.8% year over year), net profit of -KRW 5.3 billion (-76.6% year over year).

Curiox Biosystems reported preliminary Q3 2026 results (consolidated): Revenue of KRW 1.5 billion (+7.7% year over year), operating profit of -KRW 4 billion (-47.8% year over year), net profit of -KRW 5.3 billion (-76.6% year over year).

Written in code from the structured data of the filing. Reference information, not investment advice.

Key figures

Period

Q3 2026

Basis

Consolidated

Revenue

KRW 1.5 billion (+7.7% year over year)

Operating profit

-KRW 4 billion (-47.8% year over year)

Net profit

-KRW 5.3 billion (-76.6% year over year)

Filing facts

Filing type

Preliminary Earnings

Report name

Preliminary Consolidated Operating Results (Fair Disclosure)

Filed

Oct 27, 2026

Receipt number

20261027900676